{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:37:59Z","timestamp":1768257479869,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1-2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.2119\/molmed.2010.00132","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T18:51:32Z","timestamp":1294426292000},"page":"29-35","source":"Crossref","is-referenced-by-count":53,"title":["High-Mobility Group Box-1 Protein (HMGB1) Is Increased in Antineutrophilic Cytoplasmatic Antibody (ANCA)-Associated Vasculitis with Renal Manifestations"],"prefix":"10.1186","volume":"17","author":[{"given":"Annette","family":"Bruchfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marten","family":"Wendt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Bratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul R.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Tracey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Palmblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iva","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,10]]},"reference":[{"key":"1701029_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, et al. (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum. 37:187\u201392.","journal-title":"Arthritis Rheum"},{"key":"1701029_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1440-1797.2009.01101.x","volume":"14","author":"D Jayne","year":"2009","unstructured":"Jayne D. (2009) Progress of treatment in ANCA-associated vasculitis (Review). Nephrology (Carlton) 14:42\u20138.","journal-title":"Nephrology (Carlton)"},{"key":"1701029_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1196\/annals.1361.042","volume":"1051","author":"J Voswinkel","year":"2005","unstructured":"Voswinkel J, Muller A, Lamprecht P. (2005) Is PR3-ANCA formation initiated in Wegener\u2019s granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production. Ann. N. Y. Acad. Sci. 1051:12\u20139.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1701029_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1172\/JCI0215918","volume":"110","author":"H Xiao","year":"2002","unstructured":"Xiao H, et al. (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest. 110:955\u201363.","journal-title":"J. Clin. Invest."},{"key":"1701029_CR5","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1182\/blood-2005-03-0921","volume":"15","author":"MA Little","year":"2005","unstructured":"Little MA, et al. (2005) Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 15:2050\u20138.","journal-title":"Blood"},{"key":"1701029_CR6","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1189\/jlb.71.6.996","volume":"71","author":"K Hattar","year":"2002","unstructured":"Hattar K, et al. (2002) Wegener\u2019s granulomatosis: antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release-role of autocrine cell activation. J. Leukoc. Biol. 71:996\u20131004.","journal-title":"J. Leukoc. Biol."},{"key":"1701029_CR7","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.2922595","volume":"243","author":"ME Bianchi","year":"1989","unstructured":"Bianchi ME, Beltrame M, Paonessa G. (1989) Specific recognition of cruciform DNA by nuclear protein HMG1. Science 243:1056\u20139.","journal-title":"Science"},{"key":"1701029_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/embo-reports\/kvd030","volume":"1","author":"ME Bianchi","year":"2000","unstructured":"Bianchi ME, Beltrame M. (2000) Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia. EMBO Rep. 1:109\u201314.","journal-title":"EMBO Rep."},{"key":"1701029_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nri1594","volume":"5","author":"MT Lotze","year":"2005","unstructured":"Lotze MT, Tracey KJ. (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5:331\u201342.","journal-title":"Nat. Rev. Immunol."},{"key":"1701029_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang H, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248\u201351.","journal-title":"Science"},{"key":"1701029_CR11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2796.2003.01302.x","volume":"255","author":"H Wang","year":"2004","unstructured":"Wang H, Yang H, Tracey KJ. (2004) Extra cellular role of HMGB1 in inflammation and sepsis. J. Intern. Med. 255:320\u201331.","journal-title":"J. Intern. Med."},{"key":"1701029_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME. (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191\u20135.","journal-title":"Nature"},{"key":"1701029_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1084\/jem.192.4.565","volume":"192","author":"U Andersson","year":"2000","unstructured":"Andersson U, et al. (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192:565\u201370.","journal-title":"J. Exp. Med."},{"key":"1701029_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2796.2003.01204.x","volume":"254","author":"CJ Treutiger","year":"2003","unstructured":"Treutiger CJ, et al. (2003) High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 254:375\u201385.","journal-title":"J. Intern. Med."},{"key":"1701029_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0300-9475.2005.01534.x","volume":"61","author":"R Kokkola","year":"2005","unstructured":"Kokkola R, et al. (2005) RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 61:1\u20139.","journal-title":"Scand. J. Immunol."},{"key":"1701029_CR16","doi-asserted-by":"publisher","first-page":"C917","DOI":"10.1152\/ajpcell.00401.2005","volume":"290","author":"JS Park","year":"2006","unstructured":"Park JS, et al. (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 290:C917\u201324.","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1701029_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/01.shk.0000225404.51320.82","volume":"26","author":"M Yu","year":"2006","unstructured":"Yu M, et al. (2006) HMGB1 signals through tolllike receptor (TLR) 4 and TLR2. Shock 26:174\u20139.","journal-title":"Shock"},{"key":"1701029_CR18","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1002\/art.10540","volume":"46","author":"R Kokkola","year":"2002","unstructured":"Kokkola R, et al. (2002) High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum. 46:2598\u2013603.","journal-title":"Arthritis Rheum"},{"key":"1701029_CR19","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/art.11028","volume":"48","author":"R Pullerits","year":"2003","unstructured":"Pullerits R, et al. (2003) High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum. 48:1693\u2013700.","journal-title":"Arthritis Rheum"},{"key":"1701029_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1073\/pnas.2434651100","volume":"101","author":"H Yang","year":"2004","unstructured":"Yang H, et al. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U. S. A. 101:296\u2013301.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1701029_CR21","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/art.11161","volume":"48","author":"R Kokkola","year":"2003","unstructured":"Kokkola R, et al. (2003) Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48:2052\u20138.","journal-title":"Arthritis Rheum"},{"key":"1701029_CR22","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/01.CCM.0000155991.88802.4D","volume":"33","author":"J Sunden-Cullberg","year":"2005","unstructured":"Sunden-Cullberg J, et al. (2005) Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit. Care Med. 33:564\u201373.","journal-title":"Crit. Care Med."},{"key":"1701029_CR23","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1160\/TH05-05-0316","volume":"94","author":"T Hatada","year":"2005","unstructured":"Hatada T, et al. (2005) Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb. Haemost. 94:975\u20139.","journal-title":"Thromb. Haemost."},{"key":"1701029_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2119\/2006-00108.Goldstein","volume":"13","author":"RS Goldstein","year":"2007","unstructured":"Goldstein RS, et al. (2007) Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol. Med. 13:210\u20135.","journal-title":"Mol. Med."},{"key":"1701029_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2119\/2007-00107.Bruchfeld","volume":"14","author":"A Bruchfeld","year":"2008","unstructured":"Bruchfeld A, et al. (2008) High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD). Mol. Med. 14:109\u201315.","journal-title":"Mol. Med."},{"key":"1701029_CR26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 130:461\u201370.","journal-title":"Ann. Intern. Med."},{"key":"1701029_CR27","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1002\/art.27590","volume":"62","author":"T Ostberg","year":"2010","unstructured":"Ostberg T, et al. (2010) Protective targeting of HMGB1 in a spontaneous arthritis model. Arthritis Rheum. 62:2963\u201372.","journal-title":"Arthritis Rheum"},{"key":"1701029_CR28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","volume":"41","author":"AD Booth","year":"2003","unstructured":"Booth AD, et al. (2003) Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am. J. Kidney Dis. 41:776\u201384.","journal-title":"Am. J. Kidney Dis."},{"key":"1701029_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.7326\/0003-4819-143-9-200511010-00005","volume":"143","author":"SL Hogan","year":"2005","unstructured":"Hogan SL, et al. (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann. Intern. Med. 143:621\u201331.","journal-title":"Ann. Intern. Med."},{"key":"1701029_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/sj.ki.5000167","volume":"69","author":"P Hewins","year":"2006","unstructured":"Hewins P, et al. (2006) IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int. 69:605\u201315.","journal-title":"Kidney Int."},{"key":"1701029_CR31","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1186\/ar2387","volume":"10","author":"E Sundberg","year":"2008","unstructured":"Sundberg E, et al. (2008) Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients: a prospective clinical study. Arthritis Res. Ther. 10:R33.","journal-title":"Arthritis Res. Ther."},{"key":"1701029_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa041884","volume":"352","author":"Wegener\u2019s Granulomatosis Etanercept Trial WGET Research Group.","year":"2005","unstructured":"Wegener\u2019s Granulomatosis Etanercept Trial (WGET) Research Group. (2005) Etanercept plus standard therapy for Wegener\u2019s granulomatosis. N. Engl. J. Med. 352:351\u201361.","journal-title":"N. Engl. J. Med."},{"key":"1701029_CR33","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/labinvest.2010.64","volume":"90","author":"Y Oyama","year":"2010","unstructured":"Oyama Y, et al. (2010) High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy. Lab. Invest. 90:853\u201366.","journal-title":"Lab. Invest."},{"key":"1701029_CR34","doi-asserted-by":"publisher","first-page":"c194","DOI":"10.1159\/000118942","volume":"108","author":"F Sato","year":"2008","unstructured":"Sato F, et al. (2008) High mobility group box chromosomal protein 1 in patients with renal diseases. Nephron. Clin. Pract. 108:c194\u2013201.","journal-title":"Nephron. Clin. Pract."},{"key":"1701029_CR35","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1136\/ard.2009.119172","volume":"69","author":"D Wibisono","year":"2010","unstructured":"Wibisono D, et al. (2010) Serum HMGB1 levels are increased in active Wegener\u2019s granulomatosis and differentiate between active forms of ANCA-associated vasculitis. Ann. Rheum. Dis. 69:1888\u20139.","journal-title":"Ann. Rheum. Dis."},{"key":"1701029_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1189\/jlb.0306196","volume":"81","author":"V Urbonaviciute","year":"2007","unstructured":"Urbonaviciute V, F\u00fcrnrohr BG, Weber C, Haslbeck M, Wilhelm S, Herrmann M, Voll RE. (2007) Factors masking HMGB1 in human serum and plasma. J. Leukoc. Biol. 81:67\u201374.","journal-title":"J. Leukoc. Biol."},{"key":"1701029_CR37","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/ard.2007.071936","volume":"67","author":"C Mukhtyar","year":"2008","unstructured":"Mukhtyar C, et al. (2008) Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann. Rheum. Dis. 67:1004\u201310.","journal-title":"Ann. Rheum. Dis."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crossref.org\/molmed.2010.00132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2010.00132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T19:49:38Z","timestamp":1685908178000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2010.00132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,10]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1701029"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2010.00132","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,10]]}}}